• 1
    The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 813.
  • 2
    Harris A. Current regimens for treatment of Helicobacter pylori infection. Br Med Bull 1998; 54: 195205.
  • 3
    Penston JG & McColl KEL. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997; 43: 22343.
  • 4
    Gasbarrini A, Ojetti V & Armuzzi A, et al. Efficacy of a multistep strategy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 7983.DOI: 10.1046/j.1365-2036.2000.00685.x
  • 5
    Cammarota G, Cannizzaro O & Ojetti V, et al. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxicillin or tinidazole for Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 737.DOI: 10.1046/j.1365-2036.2000.00664.x
  • 6
    Deltenre M, Ntounda R, Jonas C & De Koster E. Eradication of Helicobacter pylori: why does it fail? Ital J Gastroenterol Hepatol 1998; 30(Suppl. 3): S3268.
  • 7
    De Boer WA & Tytgat GNJ. The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995; 30: 4017.
  • 8
    Marteau P & Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993; 12: 20720.
  • 9
    Nord CE, Heimdal A & Kager L. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scand J Infect Dis 1986; 49: 6472.
  • 10
    Adamsson I, Nord CE, Lundquist P, Sjostedt S & Edlund C. Comparative effects of omeprazole, amoxycillin, plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999; 44: 62940.DOI: 10.1093/jac/44.5.629
  • 11
    Lewis SJ & Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998; 12: 80722.DOI: 10.1046/j.1365-2036.1998.00386.x
  • 12
    Saxelin M. Lactobacillus GG—A human probiotic strain with thorough clinical documentation. Food Rev Int 1997; 13: 293313.
  • 13
    Armuzzi A, Cremonini F & Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2000, in press.
  • 14
    Gasbarrini A, Anti M & Franceschi F, et al. The CUE (Catholic University Epidemiological) study: prevalence of H. pylori infection in a population working at an university hospital. Eur J Gastroenterol Hepatol 2000, in press.
  • 15
    De Boer WA, Thys JC, Borody TJ, Graham DY, O’Morain CO & Tytgat GNJ. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepatol 1996; 8: 6413.
  • 16
    Peura D. Helicobacter pylori: rational management options. Am J Med 1998; 105: 42430.DOI: 10.1016/s0002-9343(98)00297-6
  • 17
    Fuller R. Probiotics in human medicine. Ann Med 1990; 22: 3741.
  • 18
    Isolauri E, Kaila M, Mikkanen H, Ling WH & Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994; 12: 2595600.
  • 19
    Hilton E, Kolakowski P, Singer C & Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Trav Med 1997; 4: 413.
  • 20
    Biller JA, Katz AJ, Flores AF, Buie TM & Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995; 21: 2246.
  • 21
    Siitonen S, Vapaatalo H & Salminen S, et al. Effect of Lactobacillus GG Yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22: 579.
  • 22
    Arvola T, Laiho K & Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104: e64e64.
  • 23
    Vandehoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV & Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 5648.
  • 24
    Charteris WP, Kelly PM, Morelli L & Collins JK. Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Prot 1998; 61: 163643.
  • 25
    Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L & Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992; 37: 1218.
  • 26
    De Boer WA, Driessen WMM, Jansz AR & Tytgat GNJ. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 81720.
  • 27
    Borody TJ, Andrews P, Fracchia G, Brandl S, Shortis NP & Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37: 47781.
  • 28
    Thys JC, Zwet AA & Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993; 28: 9348.
  • 29
    Tomomasa T, Kuroume T, Arai H, Wakasashi K & Itoh Z. Erythromicin induces migrating motor complexes in human gastrointestinal tract. Dig Dis Sci 1986; 31: 15761.
  • 30
    Bortolotti M, Brunelli F, Sarti P, Mari C & Miglioli M. Effects of oral clarithromycin and amoxicillin on interdigestive gastrointestinal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. Aliment Pharmacol Ther 1998; 12: 10215.DOI: 10.1046/j.1365-2036.1998.00401.x
  • 31
    Michetti P, Dorta G & Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60: 2039.